DNTT and breast carcinoma: TUNEL enables labeling of the 3′-freehydroxyl ends of the fragmented DNA with fluorescein–dUTP, catalyzed by terminal deoxynucleotidyltransferase [23]; therefore, the TUNEL assay was utilized to further clarify cellular apoptosis in Dox-treated breast cancer cells with or without baicalin.